Radoshitzky, Sheli R.
Iversen, Patrick
Lu, Xianghan
Zou, Jing
Kaptein, Suzanne J. F.
Stuthman, Kelly S.
Van Tongeren, Sean A.
Steffens, Jesse
Gong, Ruoyu
Truong, Hoa
Sapre, Annapurna A.
Yang, Huiling
Xie, Xiaodong
Chia, Jia Jun
Song, Zhijuan J.
Leventhal, Stacey M.
Chan, Josolyn
Shornikov, Alex
Zhang, Xin
Cowfer, David
Yu, Helen
Warren, Travis
Cihlar, Tomas
Porter, Danielle P.
Neyts, Johan
Shi, Pei-Yong
Wells, Jay
Bilello, John P.
Feng, Joy Y.
Funding for this research was provided by:
Gilead Sciences
China Scholarship Council (201906170033)
Article History
Received: 16 November 2022
Accepted: 6 February 2023
First Online: 23 February 2023
Competing interests
: XL, RG, HT, AAS, HY, XX, JJC, ZJS, SML, JC, AS, DC, HY, TC, DPP, JPB and JYF possess potential competing interests and the remaining authors do not have any competing interests. XZ received funding of the China Scholarship Council (Grant No.201906170033). This article reflects the views of the authors and should not be construed to represent the FDA’s views or policies.